Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Roxadustat significantly increased haemoglobin levels for chronic kidney disease patients with anaemia in Phase III OLYMPUS and ROCKIES trials
-
Calquence data to show improved progression-free survival in Phase III front-line chronic lymphocytic leukaemia trial at ASH 2019 Annual Meeting
-
AstraZeneca announces three large-scale initiatives in China to advance global medicine research and development
-
AstraZeneca to present pivotal roxadustat Phase III data at the American Society of Nephrology Kidney Week 2019
-
AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia
-
Imfinzi and Imfinzi plus tremelimumab delayed disease progression in Phase III POSEIDON trial for 1st-line treatment of Stage IV non-small cell lung cancer
-
Year-to-date and Q3 2019 Results
-
AstraZeneca commits $35m to help young people tackle the threat of non-communicable diseases
-
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes
-
Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
